Can I take candesartan while pregnant or breastfeeding?

A plain-words look at what the NHS, the US drug label and LactMed say about candesartan.

In short

Pregnancy: Let your doctor know if you're pregnant or planning to be.

Breastfeeding: Let your doctor know if you're breastfeeding, because breastfeeding while taking candesartan carries a risk of side effects for your baby.

Your doctor, midwife or pharmacist can help you decide.

What this means for you

Pregnancy

Breastfeeding

When to get help

Talk to your doctor or pharmacist

This page is educational, not advice for your own situation. Talk to your doctor, midwife or pharmacist before you start, stop or change any medicine in pregnancy or while breastfeeding.

The details: what each source says

Candesartan in pregnancy

The NHS says

Let your doctor know if you're pregnant or planning to be.

Candesartan is not used in pregnancy, as it can affect your baby's development in the womb and can lead to your baby being born early (premature).

Your doctor can suggest another medicine for high blood pressure that is safer to take while pregnant.

In our words, from the NHS page Candesartan (nhs.uk). Contains public sector information licensed under the Open Government Licence v3.0 (OGL v3.0). The NHS does not endorse this site.

The US drug label says

8.1 Pregnancy Pregnancy Category D Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death. Resulting oligohydramnios can be associated with fetal lung hypoplasia and skeletal deformations. Potential neonatal adverse effects include skull hypoplasia, anuria, hypotension, renal failure, and death. When pregnancy is detected, discontinue candesartan cilexetil as soon as possible. These adverse outcomes are usually associated with use of these drugs in the second and third trimester of pregnancy. Most epidemiologic studies examining fetal abnormalities after exposure to antihypertensive use in the first trimester have not distinguished drugs affecting the renin-angiotensin system from other antihypertensive agents. Appropriate management of maternal hypertension during pregnancy is important to optimize outcomes for both mother and fetus. In the unusual case that there is no appropriate alternative to therapy with drugs affecting the renin-angiotensin system for a particular patient, apprise the mother of the potential risk to the fetus.

Prescribing label, section “8.1 Pregnancy” (opening excerpt): CANDESARTAN CILEXETIL (oral), Alembic Pharmaceuticals Limited. Read the full section on DailyMed. Quoted verbatim; US labels are written for US prescribers and patients.

More on candesartan in pregnancy: Bumps (Best Use of Medicines in Pregnancy) leaflet (external site).

Candesartan while breastfeeding

The NHS says

Let your doctor know if you're breastfeeding, because breastfeeding while taking candesartan carries a risk of side effects for your baby.

A doctor may advise you to carry on with candesartan if the benefits are greater than the risks, or may suggest trying another type of medicine for high blood pressure while you breastfeed.

If you're breastfeeding while taking candesartan and anything about your baby worries you, talk to a healthcare professional or call NHS 111 (in the UK).

In our words, from the NHS page Candesartan (nhs.uk). Contains public sector information licensed under the Open Government Licence v3.0 (OGL v3.0). The NHS does not endorse this site.

LactMed says

Preliminary evidence suggests that candesartan passes poorly into milk and is barely detectable in the plasma of breastfed infants. Use of candesartan is not a reason to discontinue nursing, but use caution in newborn and preterm infants.

“Summary of Use during Lactation”, LactMed record “Candesartan” (LM727), quoted verbatim. Everything LactMed reports about Candesartan while breastfeeding.

The US prescribing label says

Nursing Mothers It is not known whether candesartan is excreted in human milk, but candesartan has been shown to be present in rat milk. Because of the potential for adverse effects on the nursing infant, a decision should be made whether to discontinue nursing or discontinue candesartan cilexetil, taking into account the importance of the drug to the mother.

Prescribing label, section “Nursing Mothers”: CANDESARTAN CILEXETIL (oral), Alembic Pharmaceuticals Limited. Label on DailyMed. Quoted verbatim; US labels are written for US prescribers and patients.

Sources

  1. NHS, Candesartan (nhs.uk), page last reviewed 18 March 2026. Paraphrased. Contains public sector information licensed under the Open Government Licence v3.0.
  2. US drug label: CANDESARTAN CILEXETIL (oral), Alembic Pharmaceuticals Limited, human prescription drug, label effective 27 January 2023, set ID d5b43fa0-6678-4219-99f1-10d273d49baf. DailyMed (National Library of Medicine). Public domain; quoted verbatim.
  3. Drugs and Lactation Database (LactMed), National Institute of Child Health and Human Development (NICHD), via NCBI Bookshelf, record “Candesartan” (LM727), bulk release of 22 September 2026. LactMed on NCBI Bookshelf. Public domain; quoted verbatim. LactMed is a registered trademark of the U.S. Department of Health and Human Services.
  4. Bumps (Best Use of Medicines in Pregnancy), UK Teratology Information Service: Bumps (Best Use of Medicines in Pregnancy) leaflet. Linked, not reproduced.

Sources checked 26 September 2026. How we source and check every page.

Educational summary of named sources, not medical advice.